# RELEVARE PHARMACEUTICALS INC: Form D filings

RELEVARE PHARMACEUTICALS INC, a biotechnology company in Brisbane Queenland, Australia, filed 4 Form D notices with the SEC between 2010 and 2012. The latest, on June 15, 2012, reports $750,000 sold of a $750,000 offering to 1 investor.

Find out what RELEVARE PHARMACEUTICALS INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20RELEVARE%20PHARMACEUTICALS%20INC%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=RELEVARE%20PHARMACEUTICALS%20INC&page=%2Fdata%2Fform-d%2Fcompany%2Frelevare-pharmaceuticals-inc-1455487)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20RELEVARE%20PHARMACEUTICALS%20INC%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=RELEVARE%20PHARMACEUTICALS%20INC&page=%2Fdata%2Fform-d%2Fcompany%2Frelevare-pharmaceuticals-inc-1455487)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Biotechnology](https://specstream.ai/data/form-d/industry/biotechnology): 1,568 rows, by operating companies, filed since November 1, 2024, $78.40, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/biotechnology
- [Form D filings](https://specstream.ai/data/form-d): 44,302 rows, by operating companies, filed since November 1, 2024, $523.02, or the new rows each week for $92.05 a month. Buy: https://specstream.ai/data/form-d

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: LEVEL 5 CENTRAL PLAZA 2, 66 EAGLE STREET, Brisbane Queenland, Australia, 4001
- Phone: 61730096850
- Industry: Biotechnology
- Entity type: Corporation
- Incorporated in: Delaware
- Year incorporated: 2008
- Revenue range: No Revenues
- Exemptions claimed: Rule 506
- SEC identifier (CIK): 1455487

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Jun 15, 2012 | New notice | $750,000 | $750,000 | $0 | 1 | Sep 15, 2011 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1455487/000145548712000005/0001455487-12-000005-index.htm) |
| Mar 2, 2011 | New notice | Indefinite | $0 | Indefinite | 0 | Nov 16, 2010 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1455487/000145548711000002/0001455487-11-000002-index.htm) |
| Apr 20, 2010 | New notice | $3,161,608 | $3,040,682 | $120,926 | 3 | Mar 15, 2010 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1455487/000145548710000004/0001455487-10-000004-index.htm) |
| Apr 20, 2010 | New notice | $5,345,405 | $5,345,405 | $0 | 4 | Sep 21, 2009 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1455487/000145548710000003/0001455487-10-000003-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| ANDREW HARPUR MICHELL | Director |  |

[Every Form D from the week of Jun 11, 2012](https://specstream.ai/data/form-d/week/2012-06-11) · [All recent Biotechnology filings](https://specstream.ai/data/form-d/industry/biotechnology)

Read from SEC EDGAR. Amount sold is what RELEVARE PHARMACEUTICALS INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).